| Stage | ARMK | % of rev | MCD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.1B | 100.00% | $7.1B | 100.00% | MCD ×1.40 |
| Gross profit | $5.1B | 100.00% | $4.3B | 60.30% | ARMK +39.7pp |
| Operating income | $216M | 4.26% | $3.3B | 47.02% | MCD +42.8pp |
| Pre-tax income | $136M | 2.68% | $2.9B | 41.36% | MCD +38.7pp |
| Net income | $98M | 1.93% | $2.4B | 33.27% | MCD +31.3pp |
| Stage | ARMK | MCD | Gap · A − B |
|---|---|---|---|
| Revenue | $5.1B100.00% | $7.1B100.00% | MCD ×1.40 |
| Gross profit | 100.00%$5.1B | 60.30%$4.3B | ARMK +39.7pp |
| Operating income | 4.26%$216M | 47.02%$3.3B | MCD +42.8pp |
| Pre-tax income | 2.68%$136M | 41.36%$2.9B | MCD +38.7pp |
| Net income |
| 1.93%$98M |
| 33.27%$2.4B |
| MCD +31.3pp |
No shared counterparties.